Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:JNJNYSE:MRK On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeJNJJohnson & Johnson$155.90+0.2%$153.68$140.68▼$169.99$375.37B0.418.06 million shs3.48 million shsMRKMerck & Co., Inc.$80.97-1.7%$79.20$73.31▼$129.93$203.22B0.3913.28 million shs7.73 million shs13 Stocks Institutional Investors Won't Stop BuyingWhich stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceJNJJohnson & Johnson0.00%+2.27%+1.64%+1.88%+7.06%MRKMerck & Co., Inc.0.00%+2.58%+3.44%-0.63%-35.66%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationJNJJohnson & Johnson4.8498 of 5 stars2.35.04.23.93.11.71.9MRKMerck & Co., Inc.4.9962 of 5 stars3.23.05.04.23.02.53.8Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceJNJJohnson & Johnson 2.55Moderate Buy$170.889.61% UpsideMRKMerck & Co., Inc. 2.43Hold$109.1934.85% UpsideCurrent Analyst Ratings BreakdownLatest MRK and JNJ Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails6/5/2025JNJJohnson & JohnsonRoyal Bank Of CanadaSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOutperform ➝ Outperform$181.005/20/2025MRKMerck & Co., Inc.Cantor FitzgeraldSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeOverweight ➝ Cautious5/14/2025MRKMerck & Co., Inc.CitigroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Neutral$115.00 ➝ $84.005/13/2025JNJJohnson & JohnsonLeerink PartnrsSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeStrong-Buy ➝ Hold5/13/2025JNJJohnson & JohnsonLeerink PartnersSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeOutperform ➝ Market Perform$169.00 ➝ $153.004/24/2025JNJJohnson & JohnsonBenchmarkSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeStrong-Buy4/22/2025MRKMerck & Co., Inc.Cantor FitzgeraldSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageNeutral$85.004/17/2025JNJJohnson & JohnsonBarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetEqual Weight ➝ Equal Weight$166.00 ➝ $165.004/17/2025MRKMerck & Co., Inc.GuggenheimSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$115.00 ➝ $115.004/16/2025JNJJohnson & JohnsonSanford C. BernsteinSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingMarket Perform ➝ Market Perform4/16/2025JNJJohnson & JohnsonRoyal Bank Of CanadaSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOutperform ➝ Outperform$181.00 ➝ $181.00(Data available from 7/5/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookJNJJohnson & Johnson$88.82B4.22$13.11 per share11.89$29.69 per share5.25MRKMerck & Co., Inc.$64.17B3.17$9.47 per share8.55$18.33 per share4.42Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateJNJJohnson & Johnson$14.07B$8.9915.5214.082.3624.42%33.46%13.30%7/16/2025 (Estimated)MRKMerck & Co., Inc.$17.12B$6.8710.398.180.8427.27%43.23%17.11%7/29/2025 (Estimated)Latest MRK and JNJ EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails7/29/2025Q2 2025MRKMerck & Co., Inc.$2.03N/AN/AN/A$15.92 billionN/A7/16/2025Q2 2025JNJJohnson & Johnson$2.65N/AN/AN/A$22.85 billionN/A4/24/2025Q1 2025MRKMerck & Co., Inc.$2.16$2.22+$0.06$2.01$15.59 billion$15.53 billion4/15/2025Q1 2025JNJJohnson & Johnson$2.59$2.77+$0.18$4.54$21.65 billion$21.89 billionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthJNJJohnson & Johnson$5.203.34%N/A57.84%64 YearsMRKMerck & Co., Inc.$3.244.00%N/A47.16%14 YearsLatest MRK and JNJ DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date5/27/2025MRKMerck & Co., Inc.quarterly$0.814.18%6/16/20256/16/20257/8/20254/15/2025JNJJohnson & Johnsonquarterly$1.303.37%5/27/20255/27/20256/10/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioJNJJohnson & Johnson0.491.261.03MRKMerck & Co., Inc.0.691.411.16Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipJNJJohnson & Johnson69.55%MRKMerck & Co., Inc.76.07%Insider OwnershipCompanyInsider OwnershipJNJJohnson & Johnson0.16%MRKMerck & Co., Inc.0.13%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableJNJJohnson & Johnson138,1002.41 billion2.40 billionOptionableMRKMerck & Co., Inc.75,0002.51 billion2.51 billionOptionableMRK and JNJ HeadlinesRecent News About These CompaniesMerck & Co., Inc. (NYSE:MRK) Shares Bought by Quattro Financial Advisors LLCJuly 5 at 8:51 AM | marketbeat.comAdell Harriman & Carpenter Inc. Decreases Stock Holdings in Merck & Co., Inc. (NYSE:MRK)July 5 at 8:51 AM | marketbeat.comSimmons Bank Has $6.68 Million Stock Position in Merck & Co., Inc. (NYSE:MRK)July 5 at 8:33 AM | marketbeat.comHM Payson & Co. Decreases Position in Merck & Co., Inc. (NYSE:MRK)July 5 at 8:32 AM | marketbeat.comMerck & Co., Inc. (NYSE:MRK) Shares Sold by Bank of New York Mellon CorpJuly 5 at 8:25 AM | marketbeat.comWorld Investment Advisors Increases Stake in Merck & Co., Inc. (NYSE:MRK)July 5 at 8:11 AM | marketbeat.comTruist Financial Corp Sells 1,211,541 Shares of Merck & Co., Inc. (NYSE:MRK)July 5 at 7:36 AM | marketbeat.comCapital Investment Advisory Services LLC Increases Position in Merck & Co., Inc. (NYSE:MRK)July 5 at 7:16 AM | marketbeat.comImpax Asset Management Group plc Sells 46,275 Shares of Merck & Co., Inc. (NYSE:MRK)July 5 at 6:53 AM | marketbeat.comMerck & Co., Inc. (NYSE:MRK) Shares Purchased by Brookstone Capital ManagementJuly 5 at 6:45 AM | marketbeat.comMerck & Co., Inc. (NYSE:MRK) Stake Cut by Huntleigh Advisors Inc.July 5 at 6:35 AM | marketbeat.comOneDigital Investment Advisors LLC Sells 4,946 Shares of Merck & Co., Inc. (NYSE:MRK)July 5 at 6:27 AM | marketbeat.comMeritage Portfolio Management Has $238,000 Stock Holdings in Merck & Co., Inc. (NYSE:MRK)July 5 at 5:24 AM | marketbeat.comMerck & Co., Inc. (NYSE:MRK) Trading Down 1.7% - Here's WhyJuly 4 at 12:13 PM | marketbeat.comKintegral Advisory LLC Sells 32,761 Shares of Merck & Co., Inc. (NYSE:MRK)July 4 at 8:38 AM | marketbeat.comMerck & Co., Inc. (NYSE:MRK) Shares Sold by Nichols & Pratt Advisers LLP MAJuly 4 at 8:28 AM | marketbeat.comIFM Investors Pty Ltd Boosts Stock Holdings in Merck & Co., Inc. (NYSE:MRK)July 4 at 8:02 AM | marketbeat.comTD Cowen Maintains Hold Rating on Merck After Enflonsia Vaccine UpdateJuly 4 at 7:28 AM | msn.comAvantax Planning Partners Inc. Has $8.33 Million Position in Merck & Co., Inc. (NYSE:MRK)July 4 at 7:27 AM | marketbeat.comCalamos Advisors LLC Decreases Stock Holdings in Merck & Co., Inc. (NYSE:MRK)July 4 at 7:03 AM | marketbeat.comRevisor Wealth Management LLC Invests $327,000 in Merck & Co., Inc. (NYSE:MRK)July 4 at 5:26 AM | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeMRK and JNJ Company DescriptionsJohnson & Johnson NYSE:JNJ$155.90 +0.34 (+0.22%) Closing price 07/3/2025 03:59 PM EasternExtended Trading$155.75 -0.15 (-0.10%) As of 07/3/2025 04:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in the interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.Merck & Co., Inc. NYSE:MRK$80.97 -1.42 (-1.72%) Closing price 07/3/2025 03:59 PM EasternExtended Trading$80.99 +0.02 (+0.02%) As of 07/3/2025 04:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Rahway, NJ. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 06/30 - 07/04 The Apple Comeback Will Be Better Than the Setback Micron’s Big Q3 Drives Applied Materials’ Bullish Outlook Why Occidental's Price Dip Signals a Buying Opportunity Qualcomm’s Hold Rating Misses Strong Growth Story Rigetti Computing: Cantor's Bullish Call May Be Just the Start Insider Selling at NVIDIA Could Turn Into an Opportunity Whiplash for Investors: AeroVironment's Confusing Stock Signals Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
